MEHRUNNISA SULTANA: Open Payments
NPI 1235205410 · WEST PALM BEACH, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,177 in 115 payments from 11 companies in 2025. Trend: 2023 $2,212 · 2024 $2,024 · 2025 $2,177
Food & beverage: $2,067Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 19 | $385 |
| Neurocrine BioSciences, Inc. | 12 | $340 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 18 | $297 |
| Otsuka America Pharmaceutical, Inc. | 12 | $273 |
| ABBVIE INC. | 22 | $249 |
| E.R. Squibb & Sons, L.L.C. | 10 | $175 |
| Alkermes, Inc. | 8 | $157 |
| Janssen Pharmaceuticals, Inc | 5 | $121 |
| Vanda Pharmaceuticals Inc. | 5 | $101 |
| Lundbeck LLC | 2 | $40 |
Products named: INGREZZA, CAPLYTA, VRAYLAR, AUSTEDO XR, ABILIFY MAINTENA, COBENFY, ARISTADA, INVEGA SUSTENNA.
Industry payments across FL — which companies pay providers there.
